ctrl K

Citius Oncology Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

0.97

0.08 (8.99%)

At close: May 02, 2025, 3:00 PM

Citius Oncology Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
Cash & Equivalents	112.00	n/a	n/a
Short-Term Investments	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a
Receivables	n/a	n/a	n/a
Inventory	8.27M	n/a	n/a
Other Current Assets	n/a	n/a	n/a
Total Current Assets	10.97M	7.73M	2.69M
Property-Plant & Equipment	n/a	n/a	n/a
Goodwill & Intangibles	73.4M	40M	40M
Total Long-Term Assets	73.4M	40M	40M
Total Assets	84.37M	47.73M	42.69M
Account Payables	3.71M	1.29M	92.31K
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a
Other Current Liabilities	1.00	n/a	n/a
Total Current Liabilities	32.7M	21.05M	5.85M
Long-Term Debt	3.8M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a
Total Long-Term Liabilities	5.53M	1.15M	576K
Total Liabilities	38.23M	22.2M	6.42M
Total Debt	3.8M	n/a	n/a
Common Stock	7.16K	167.00	242.00
Retained Earnings	-39.28M	-18.13M	-5.43M
Comprehensive Income	n/a	n/a	n/a
Shareholders Equity	46.14M	25.54M	36.27M
Total Investments	n/a	n/a	n/a